Bristol Myers Squibb
Global biopharma company developing innovative medicines
Based in NY
🤖
AI Overview
With $1.2M in lobbying spend across 22 quarterly filings, Bristol Myers Squibb is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 3 issue areas. Active from 2021 to 2025.
$1.2M
Total Spend
5
Years Active
1
Firms Hired
12
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $200K |
| 2022 | $300K |
| 2023 | $240K |
| 2024 | $220K |
| 2025 | $260K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Health Issues
- •Prescription drug access, User Fee Reauthorization, Innovation
- •reconciliation, FY2022 budget, appropriations
- •prescription drug access and affordability, pricing, transparency
- •H.R. 1319, American Rescue Pan of 2021 implementation
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.